China Universal Asset Management Company’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.7K | Buy |
|
|||||
|
2025
Q1 | $62.9K | Sell |
|
|||||
|
2024
Q4 | $164K | Buy |
|
|||||
|
2024
Q3 | $226K | Buy |
|
|||||
|
2024
Q2 | $112K | Sell |
|
|||||
|
2024
Q1 | $221K | Buy |
|
|||||
|
2023
Q4 | $100K | Buy |
|
|||||
|
2023
Q3 | $33.9K | Buy |
|
|||||
|
2023
Q2 | $21.5K | Sell |
|
|||||
|
2023
Q1 | $25K | Buy |
|
|||||
|
2022
Q4 | $19.1K | Buy |
|
|||||
|
2022
Q3 | $31K | Buy |
|